Bfl-1-IN-2

Overview

Bfl-1-IN-2 (Compound 13) is a reversible and covalent inhibitor of Bfl-1 ( IC 50 : 4.3 μM). Bfl-1-IN-2 acts by binding to Cys55 of Bfl-1 .

Application

Products | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Ovarian Cancer | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Bcl-2 Family

Product Information

• Catalog No.: HY-163624
• CAS No.: 3057626-34-0
• Molecular Formula: C23H22F3N2O2P
• Molecular Weight: 446.40
• Purity: 99.76%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 5 mg/mL (11.20 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source